Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS)
- 31 May 2000
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 139 (5) , 820-823
- https://doi.org/10.1016/s0002-8703(00)90013-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Streptokinase . . . never againEuropean Heart Journal, 1999
- Staphylokinase: a potent, uniquely fibrin-selective thrombolytic agentNature Medicine, 1998
- A Comparison of Reteplase with Alteplase for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarctionAmerican Heart Journal, 1997
- Long-term Implications of Reocclusion on Left Ventricular Size and Function After Successful Thrombolysis for First Anterior Myocardial InfarctionCirculation, 1997
- A Randomized Trial of Recombinant Staphylokinase Versus Alteplase for Coronary Artery Patency in Acute Myocardial InfarctionCirculation, 1995
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990